Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P2OK
|
||||
Former ID |
DCL001192
|
||||
Drug Name |
HPP404
|
||||
Indication | Allergic rhinitis [ICD9: 472.0, 477, 995.3; ICD10:J00, J30, J31.0, T78.4] | Phase 1 | [1] | ||
Company |
TransTech Pharma Inc
|
||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | Antagonist | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Reactome | Histamine receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Monoamine Transport | ||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Clinical pipeline report, company report or official report of TransTech Pharma (2011). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.